INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
SS
Corporate insider

Smith Stan

DirectorCIK 0001913199

EDGAR filingsOpen in network
Disclosed transactions10
Buys / sells9 / 0
Max Insider Score47
Connections with evidence1

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Gift
G—
20.0K sh
May 1, 2024Jan 12, 2026
traded May 1, 2024
+621dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    MAIA Biotechnology, Inc.Director · Nov 26, 2025
44
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY
$9,959
2,700 sh
Sep 19, 2022
Jan 12, 2026
traded Sep 19, 2022
+1211d
SEC FORM 4

Evidence

35
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$70K
57.2K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

47
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$78K
57.2K sh
Dec 22, 2025Dec 23, 2025
traded Dec 22, 2025
+1dSEC FORM 4

Evidence

47
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$5,450
4,580 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

47
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$5,496
4,580 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

47
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$5,495
4,580 sh
Dec 5, 2025Dec 9, 2025
traded Dec 5, 2025
+4dSEC FORM 4

Evidence

41
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$16K
15.0K sh
Nov 26, 2025Dec 1, 2025
traded Nov 26, 2025
+5dSEC FORM 4

Evidence

35
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$9,900
10.0K sh
Nov 24, 2025Nov 26, 2025
traded Nov 24, 2025
+2dSEC FORM 4

Evidence

35
SS
Smith StanDirector
MAIAMAIA Biotechnology, Inc.
Open-market purchase
BUY$15K
15.0K sh
Nov 25, 2025Nov 26, 2025
traded Nov 25, 2025
+1dSEC FORM 4

Evidence